Nursing and Health Professions
Intensive Care
100%
Economic Evaluation
100%
Thromboembolism
100%
Intensive Care Unit
66%
Low Molecular Weight Heparin
50%
Heparin
50%
Cost Effectiveness Analysis
33%
Bleeding
33%
Laboratory Test
16%
Confidence Interval
16%
Healthcare System
16%
Ward
16%
Drug Therapy
16%
Bootstrapping
16%
Lung Embolism
16%
Deep Vein Thrombosis
16%
Critical Illness
16%
Thrombosis
16%
Venous Thromboembolism
16%
Dalteparin
16%
Heparin Induced Thrombocytopenia
16%
Radiodiagnosis
16%
Medicine and Dentistry
Health Care Cost
100%
Randomized Controlled Trial
100%
Thromboembolism
100%
Intensive Care
100%
Intensive Care Unit
33%
Low Molecular Weight Heparin
25%
Heparin
25%
Cost-Effectiveness Analysis
16%
Subgroup Analysis
16%
Laboratory Test
8%
Clinical Trial
8%
Drug Therapy
8%
Thrombosis
8%
Bleeding
8%
Bootstrapping
8%
Major Bleeding
8%
Deep Vein Thrombosis
8%
Venous Thromboembolism
8%
Dalteparin Sodium
8%
Critical Illness
8%
Pulmonary Embolism
8%
Heparin-Induced Thrombocytopenia
8%
Radiodiagnosis
8%
Pharmacology, Toxicology and Pharmaceutical Science
Thromboembolism
100%
Randomized Controlled Trial
100%
Heparin
50%
Low Molecular Weight Heparin
50%
Bleeding
33%
Venous Thromboembolism
16%
Clinical Trial
16%
Lung Embolism
16%
Thrombosis
16%
Dalteparin
16%
Deep Vein Thrombosis
16%
Heparin Induced Thrombocytopenia
16%
Critical Illness
16%
Keyphrases
Generation Mean Analysis
16%
Radiological Tests
16%
Diagnostic Radiology
16%
Personnel Costs
16%